Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Moodys
Chinese Patent Office
Teva
Merck
US Department of Justice
Fish and Richardson
Dow
Cantor Fitzgerald

Generated: April 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: regorafenib

« Back to Dashboard

regorafenib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Bayer Hlthcare STIVARGA regorafenib TABLET;ORAL 203085 NDA Bayer HealthCare Pharmaceuticals Inc. N 50419-171-04
Bayer Hlthcare STIVARGA regorafenib TABLET;ORAL 203085 NDA Bayer HealthCare Pharmaceuticals Inc. N 50419-171-00
Bayer Hlthcare STIVARGA regorafenib TABLET;ORAL 203085 NDA Bayer HealthCare Pharmaceuticals Inc. N 50419-171-03
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Johnson and Johnson
Merck
Queensland Health
QuintilesIMS
McKinsey
Covington
Citi